Search
for
Sort by
Research 211–240 of 1000+
- Alopecia areata-like presentations with mogamulizumab therapy
- Skin Disease in Korean Human Immunodeficiency Virus Patient
- Prevalence of Dermatologic Side Effects of Mood Stabilizers in Bipolar Disorder: A Systematic Review and A Meta-Analysis
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Sodium Valproate-Induced Hyperpigmentation
- When bugs and drugs conspire: driving acneiform skin toxicity
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Response to Falotico et al’s “Biotin beware: Perils of biotin supplementation”
- Immunologic adverse reactions of β-blockers and the skin (Review)
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Difficult and rare forms of acne
- Nanoparticles for Topical Application in the Treatment of Skin Dysfunctions—An Overview of Dermo-Cosmetic and Dermatological Products
- Madarosis: A marker of many Maladies
- Safety Evaluation of Topical Valproate Application
- Childhood‐onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report
- Erythroderma: clinical and etiological study of 88 cases seen in a tertiary hospital over 25 years
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Dermatoses of Pregnancy
- Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases
- Nanotechnology-based techniques for hair follicle regeneration
- Adverse Cutaneous Reactions to Mood Stabilizers
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Cutaneous manifestations associated with substance use disorders
- Proposal for Clinical Classification of Cutaneous Manifestations in Covid-19 and in Post Vaccination Against Sars-Cov-2: An Observational Study
- Targeting integrin pathways: mechanisms and advances in therapy
- The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
- Hair Changes due to Drugs